These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18364071)

  • 1. [Potential novel biomarkers for monitoring the fibrogenic process in livers].
    Gao CF; Gressner AM; Chen C
    Zhonghua Gan Zang Bing Za Zhi; 2008 Mar; 16(3):173-4. PubMed ID: 18364071
    [No Abstract]   [Full Text] [Related]  

  • 2. Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.
    Gressner OA; Weiskirchen R; Gressner AM
    Clin Chim Acta; 2007 Jun; 381(2):107-13. PubMed ID: 17399697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Back to the future with noninvasive biomarkers of liver fibrosis.
    Guha IN
    Hepatology; 2009 Jan; 49(1):9-11. PubMed ID: 19111007
    [No Abstract]   [Full Text] [Related]  

  • 4. Proteomic approaches in the search for biomarkers of liver fibrosis.
    Cowan ML; Rahman TM; Krishna S
    Trends Mol Med; 2010 Apr; 16(4):171-83. PubMed ID: 20304704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive biomarkers FibroTest-ActiTest for replacing invasive liver biopsy: the need for change and action.
    Munteanu M
    J Gastrointestin Liver Dis; 2007 Jun; 16(2):173-4. PubMed ID: 17592566
    [No Abstract]   [Full Text] [Related]  

  • 6. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
    Berenguer M
    Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
    [No Abstract]   [Full Text] [Related]  

  • 7. The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond.
    Yilmaz Y; Ulukaya E; Dolar E
    Hepatology; 2009 Mar; 49(3):1056-7. PubMed ID: 19133647
    [No Abstract]   [Full Text] [Related]  

  • 8. Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.
    Munteanu M; Imbert-Bismut F; Messous D; Morra R; Thabut D; Lebray P; Benhamou Y; Ratziu V; Poynard T
    Clin Biochem; 2008 Sep; 41(13):1113-4. PubMed ID: 18486610
    [No Abstract]   [Full Text] [Related]  

  • 9. [The methods of estimation and monitoring liver fibrosis in patients with chronic viral hepatitis].
    Lebensztejn DM
    Pol Merkur Lekarski; 2001 Dec; 11(66):522-5. PubMed ID: 11899853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive measures of liver fibrosis.
    Rockey DC; Bissell DM
    Hepatology; 2006 Feb; 43(2 Suppl 1):S113-20. PubMed ID: 16447288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive tests for liver fibrosis.
    Mukherjee S; Sorrell MF
    Semin Liver Dis; 2006 Nov; 26(4):337-47. PubMed ID: 17051448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.
    Pinzani M; Vizzutti F; Arena U; Marra F
    Nat Clin Pract Gastroenterol Hepatol; 2008 Feb; 5(2):95-106. PubMed ID: 18253138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease.
    Gressner OA; Jafari S; Erkens M; Gao C; Stanzel S; Gressner AM
    Clin Chim Acta; 2009 May; 403(1-2):188-93. PubMed ID: 19281805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reversibility of advanced liver fibrosis--therapeutic possibility and biochemical monitoring of the disease].
    Lebensztejn DM
    Przegl Epidemiol; 2005; 59(2):535-40. PubMed ID: 16190564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive markers of liver fibrosis: playing the probabilities.
    Myers RP
    Liver Int; 2008 Dec; 28(10):1328-31. PubMed ID: 19055641
    [No Abstract]   [Full Text] [Related]  

  • 16. Towards the non-invasive diagnosis of cirrhosis: the nuts-cirrhosis connection.
    Bosch J
    J Hepatol; 2009 Jan; 50(1):4-6. PubMed ID: 19019481
    [No Abstract]   [Full Text] [Related]  

  • 17. Surrogate markers for liver fibrosis.
    Poynard T
    Med J Malaysia; 2005 Jul; 60 Suppl B():39-40. PubMed ID: 16108172
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of liver fibrosis: a concise review.
    Afdhal NH; Nunes D
    Am J Gastroenterol; 2004 Jun; 99(6):1160-74. PubMed ID: 15180741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis.
    Denzer UW; Lüth S
    Best Pract Res Clin Gastroenterol; 2009; 23(3):453-60. PubMed ID: 19505671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.